Conditions: HIV
Keywords: Combination Therapy
Allocation: RANDOMIZED | Intervention model: PARALLEL
Enrollment: 167
Healthy volunteers: no

Brief summary:
The purpose of this study is to determine if the combination of atazanavir and raltegravir taken together is safe and effective in the treatment of human immunodeficiency virus (HIV).

Detailed description:

Arms:
arm 1: Atazanavir 300 mg twice daily + Raltegravir 400 mg twice daily arm 2: Atazanavir, 300 mg once daily, + Ritonavir, 100 mg once daily, + Tenofovir 300 mg/Emtricitabine, 200 mg once daily

Interventions: intervention 1: Atazanavir intervention 2: Raltegravir intervention 3: Atazanavir intervention 4: Ritonavir intervention 5: Tenofovir/Emtricitabine
Intervention descriptions: intervention 1: Capsules, Oral, 300 mg, twice daily, 96 weeks intervention 2: Tablet, Oral, 400 mg, twice daily, 96 weeks intervention 3: Capsules, Oral, 300 mg, once daily, 96 weeks intervention 4: Capsules, Oral, 100 mg, once daily, 96 weeks intervention 5: Tablet, Oral, 300-mg Tenofovir/200-mg Emtricitabine, once daily, 96 weeks

Protocol document: